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Abstract: I n t r o d u c t i o n: Hydronephrosis is an actual pediatric problem, aff ecting children in the ante- 
and neonatal periods. Intrinsic stenosis is due to external obstruction and creates a pathophysiological 
basis of this urological pathology. Co-localization of ureter with a renal vasculature also could not be 
omitted from this point of view. Mesenchymal cells, partially telocytes, are important for local fi brosis 
development and hydronephrosis formation as well. In the current study, we focused on identifi cation of 
telocytes in the human ureters to hypothesize their role in hydronephrosis pathophysiology.
M a t e r i a l  a n d  M e t h o d s: Th e samples were taken from 18 surgically treated patients with 
hydronephrosis (due to ureteral obstruction and crossing renal vessel). Th e control group consisted of 
10 patients suff ered from a non-obstructive disease of the urinary tract — predominantly renal tumors. 
Tissue samples from a ureter were stained for c-kit, tryptase, CD34 and PDGFRα to identify telocytes. 
Routine histology was performed to analyze tissue morphology, collagen deposits and mast cell’s profi le.
Re su l t s: Telocytes were detected in the ureteral wall. In patients with hydronephrosis we revealed 
decreasing density of telocytes, the prevalence of collagen, rise in mast cells amount and the ureteral 
wall thickening. In ureters with crossing renal vessels as a primary etiologic factor more telocytes have 
been observed in comparison with the obstructive hydronephrosis.
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C o n c l u s i o n s: A declined density of telocytes accompanied hydronephrosis development. Increased 
number of mast cells in the ureteral wall refl ects a local infl ammation, while detailed observation of 
collagen/muscle deposits and density of telocytes reveal a diff erence depended on etiologic factor 
(obstruction or crossing vessel) in patients with hydronephrosis.
Key words: hydronephrosis, telocytes, CD34, ureteropelvic junction obstruction, ureter.
Introduction
Hydronephrosis is a condition characterized by an excessive amount of urine inside 
the pelvocalyceal system leading to its dilation and distension [1–3]. Th e vast 
majority of the hydronephrosis among pediatric population is due to mechanical 
ureteral obstruction. Normally, physiological hydronephrosis is common only in 
pregnancy  [4]. No doubt, one of the most frequent urological congenital pathology 
is antenatal hydronephrosis [5], aff ecting up to 4.5% of all pregnancies according 
to literature data [5, 6]. Th e prevalence is higher in boys with a peak in children 
younger than one-year-old [7]. Mostly the pathogenesis of neonatal hydronephrosis 
can be explained by ureteropelvic junction obstruction (UPJO), caused by gross 
changes in the ureteral wall [8, 9]. Grasso et al. mentioned that partial obstruction 
can result from an anomalous number or arrangement of smooth muscle cells 
within the upper ureteral wall causing peristaltic dysfunction [10]. Moreover, among 
structural changes that lead to hydronephrosis development, distinguish transient 
dilation of the collecting system, upper/lower urinary tract obstructive uropathy, and 
non-obstructive processes such as vesicoureteral refl ux [11]. All of them can occur 
during fetal development. Important to note is that hydronephrosis can be also present 
in the absence of primary obstruction [7], when it is caused by secondary to extrinsic 
crossing vessels, kinks or adhesions over the UPJ area [12–14]. In some situations, 
the ureter is located near blood vessels or aberrant renal artery partly cross its wall, 
indirectly leading to hydronephrosis development [15]. Crossing vessels can be 
evaluated as a primary cause of UPJO and lead to hydronephrosis development [16].
In antenatal and early neonatal periods cellular components of tissue organization 
are extremely important for concerning in the context of disease development. Mes-
enchymal cells are conductors and eff ectors for local fi brosis. Newly described telo-
cytes (TCs) or interstitial Cajal-like cells (ICLC) have a mesenchymal origin as well as 
communicate with surrounding cells by making contacts and indirect participation in 
angiogenesis, local fi brosis and infl ammatory reactions [17–20]. Telocytes have a vari-
able number of telopodes (Tps) (very long cellular extensions), which are probably 
the longest cellular prolongations in the human body. Th ey demonstrate specifi c di-
rect (homocellular and heterocellular junctions) and/or indirect (chemical, paracrine/
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juxtacrine signaling, microvesicles and exosomes, sex hormone and microRNAs) 
contacts with various surrounding cells and have gene expression and immunohisto-
chemical profi les [21, 22].
Telocytes are present in the upper lamina propria of the human renal pelvis, ureter, 
and urethra, as well as in kidney (in sub-capsular space) and urinary bladder [23– 26]. 
In the ureter and urinary bladder, they mainly exist in between smooth muscle 
bundles [25]. Telocytes have also been identifi ed around renal tubules and vessels 
in the kidney cortex interstitium, with shed vesicles identifi ed in close vicinity of 
TCs  [26, 27]. In the upper lamina propria of renal pelvis, ureter, and urethra these 
cells have similar ultrastructural features which were diff erent from those of bladder 
TCs:
1) thinner and longer cytoplasmic prolongations;
2) presence of dense core granules and microtubules;
3) no peripheral actin fi laments.
Telocytes are responsible for Ca2+ waves generation and neuromuscular trans-
mission, which brings them a specific value in the context of ureteral dysfunc-
tion [27– 29]. Th ey demonstrated a range of immunoreactivity to caveolin-1, estrogen 
and progesterone receptors in diff erent parts of the urinary tract (renal pelvis, ureter, 
bladder, and urethra), that indirectly indicates that each region itself might contain 
subpopulations of telocytes [23]. Also, they could establish close contacts with mac-
rophages in sub-capsular space of kidney, and with smooth muscle bundles, blood 
vessels and nerve endings in the ureter and urinary bladder [26].
Our study aimed to identify telocytes in the ureteral wall from patients with 
hydronephrosis compare their amount between study and control groups, and reveal 




Th e study retrospectively reviewed data of all children who underwent surgical 
treatment for hydronephrosis during the period 2011–2014 at Department of Pediatric 
Urology University Children’s Hospital in Cracow Jagiellonian University Medical 
College, Cracow, Poland. Th e samples were taken from 18 surgically (mean age 
22  months, male = 11) treated patients with ureteropelvic junction UPJ obstruction. 
Th e indication for surgery was based on the usual criteria (hydronephrosis detected 
with ultrasound and radionuclide renography). Th e control group consisted of 
10 patients (mean age 18 months, male = 5), suff ered from non-obstructive disease of 
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the urinary tract — predominantly renal tumors. Samples of tissue from the ureters 
were taken for further observation from the study group and control group.
Ethical approval
Th e study was conducted in accordance with the moral, ethical, regulatory and 
scientifi c principles governing clinical research. All surgical samples were retrieved 
with the approval of the Jagiellonian University Bioethical Committee using 
procedures that conformed to the Declaration of Helsinki guidelines (protocol 
number — KBET /78/B/2011).
Tissue processing
Tissue samples from fresh uretectomy specimens were collected and rinsed thoroughly 
with PBS (phosphate-buff ered saline, 0.01 M, pH = 7.4), fi xed in 4% phosphate-
buff ered paraformaldehyde, routinely processed and embedded in paraffi  n. Serial 
sections were cut and mounted on poly-L-lysine-coated glass slides.
Routine histology
Th e sections were deparaffi  nized, rehydrated and stained with either hematoxylin–
eosin (H&E) to evaluate the gross tissue organization or Masson’s trichrome staining 
to detect collagen deposits. Toluidine blue staining was performed for detection of 
mast cells.
Immunofl uorescence
Aft er deparaffi  nization and rehydration, the slides were incubated for 30 min in PBS 
with appropriate normal serum at room temperature, followed by overnight incubation 
at 4°C in a solution of PBS with appropriate normal serum containing a mixture of 
primary antibodies. Aft er 5 washes (10 min each) in PBS, the specimens were then 
incubated for 1 h at room temperature with a mixture of secondary antibodies diluted 
in PBS. Finally, the slides were washed in two changes (10 min each) of PBS and 
cover-slipped with fl uorescence mounting medium (Dako, Denmark) and covered 
glasses Menzel-Gläser. Labeled specimens were analyzed immediately. Th e primary 
antisera and secondary antibodies used are listed in Table 1.
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Table 1. Type, sources and dilution of antibodies.
Antibody Catalog number and company Dilution
Primary antibodies
Polyclonal rabbit anti-c-kit A4502, Dako 1:100
Monoclonal mouse anti-CD34 M7165, Dako 1:100
Polyclonal goat anti-PDGFR alpha AF-307-NA, R&D Systems 1:100
Monoclonal mouse anti-tryptase M7052, Dako 1:100
Secondary antibodies
Alexa Fluor 488 Goat Anti-Mouse 115-545-146, Jackson ImmunoResearch 1:400
Alexa Fluor 594 Goat Anti-Rabbit 111-585-144, Jackson ImmunoResearch 1:400
Alexa Fluor 594 Donkey Anti-Goat 705-585-003, Jackson ImmunoResearch 1:400
Alexa Fluor 488 Rabbit Anti-Mouse 315-545-045, Jackson ImmunoResearch 1:400
Microscopic examination of telocytes, mast cells, collagen deposits and the ureteral 
wall thickness Slides were examined using an MN800FL epifl uorescence microscope 
(OptaTech, Warszawa, Poland) equipped with a Olympus DP74 digital camera. Digital 
images were collected at either 200× or 400× magnifi cation. Th e qualitative analysis 
of cells was provided in 10 consecutive high-power fi elds of vision (400×) using the 
computer-based image analysis system Multiscan 18.03 soft ware (CSS, Warszawa, 
Poland). All samples were assessed by two independent specialists (each blinded 
to the other) without any knowledge of the clinical parameters or other prognostic 
factors to avoid bias. Th e use of mast cell tryptase staining enabled c-kit-positive mast 
cells to be distinguished from c-kit-positive TCs. TCs were considered cells that were 
c-Kit positive and tryptase negative concurrently, with the characteristic morphology 
in tissue samples. Additionally, cells double positive for CD34 and PDGFRα with 
the characteristic morphology and localization were also recognized as TCs. In all 
sections the immunoreactive cells found were evaluated with respect to the relative 
frequency (arbitrarily graded as very few = (+), few = +, moderate density = + +, 
multiple density = + + +). Th e percentage of collagen deposits and muscle tissue 
have been analyzed in specimens, stained with Masson trichrome. Th e collagen and 
muscle fi bers volume ration were performed in ten diff erent fi elds of each sample. Th e 
ureteral wall thickness was also evaluated in ten diff erent fi elds of each sample from 
both groups.
Mast cells were examined in samples stained with Toluidine blue and immunofl u-
orescence. Double immunolabeling for c-kit/trypatse revealed double immunopositive 
cells, which were marked as mast cells. In both kinds of staining analysis of mast cells 
was performed in ten diff erent fi elds of view and then converted and presented as the 
average number of cells per 1 mm2 of ureteral surface.
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Results
Th e histopathological changes in all ureter samples in this study were determined 
by hematoxylin–eosin and Masson’s trichrome staining (Fig. 1). Th e study group 
was characterized by the prevalence of collagen deposits in compare with the 
control group. Th e amount of muscle fi bers was lower in samples from patients with 
hydronephrosis compare with the healthy ureter. Th e gross structure of ureteral 
wall of patients aff ected by hydronephrosis was characterized by equivalent amount 
of collagen and muscle fi bers deposits. In contrast, the ureteral wall from patients 
without hydronephrosis contains in one third higher muscle fi bers than collagen 
(Table 2). Th e ureteral wall thickness was diff erent in both groups. It was thicker in 
about 17 percentage among patients with hydronephrosis as compared with control 
(Table 3). Th e ration of the collagen/muscle fi bers was equal in ureters, aff ected by 
obstruction, while tissue samples from vascular-etiologic hydronephrosis had a little 
bit less collagen and high muscle fi bers amount.
Fig. 1. Hematoxylin–eosin- and Masson’s trichrome-stained sections of human ureter. Th e ureteral wall 
sections from the control group (A, C) compared with samples from patients with hydronephorosis 
(B,  D). With Masson’s trichrome staining, collagen deposits were blue in color; muscle fi bers, red in 
color. Total magnifi cation: 200×.
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Table 2. Th e percentage of the collagen and muscle fi bers in the normal ureter and samples from patients 
with hydronephrosis.
Ureter Collagen (%) Muscle fi bers (%)
Control group 32 ± 10 54 ± 12
Hydronephrosis (obstruction) 40 ± 10 40 ± 10
Hydronephrosis (vas) 39 ± 14 42 ± 10
Table 3. Ureteral wall thickness in the control and study groups.
Control group Hydronephrosis
Ureteral wall thickness (μm) 685 ± 228 800 ± 212
An average amount of mast cells measured in ureteral wall from patients with and 
without hydronephrosis was diff erent. Due to sensitivity of immunostaining, results 
were higher in samples labeled by c-kit/tryptase antibodies in compare with routine 
histology. Nevertheless, common trend was revealed in both types of staining: the 
number of mast cells in ureters from aff ected by hydronephrosis patients was about 
1.5 times higher than in unaff ected children. Consequently, this indirectly indicates 
the infl ammation, that commonly accompanied the studied pathology (Table 4).
Table 4. Mast cells’s profi le in the control and study groups evaluated in two kinds of staining (Toluidine 
blue staining and c-Kit immunohistochemistry).
Control group Patientswith hydronephrosis
Mast cells amount (toluidine blue staining) 25.1 ± 13 56.1 ± 20.9
Mast cells amount (IHC labeling) 38.7 ± 18.5 81.8 ± 26.9
Double immunopositive cells for CD34 and PDGFRα have been detected in 
the control group, within muscle layer of the ureteral wall (Fig. 2). Based on its 
morphology, immunoprofi le and localization in the tissue, we considered that they 
represent ureteral telocytes. Some of these cells have been seen under uroepithelium. 
Th e control group has more double-positive cells in comparison with all samples 
from the study groups. In the ureter form patients with obstructive hydronephrosis, 
less telocytes have been revealed. Th e scanty architectonic of cellular pattern was 
mostly due to a prevalence of the collagen. Tissue samples from vascular etiology 
of hydronephrosis were characterized by relative intensive immunolabeling for 
mentioned markers than obstructive forms. Th e same results we had analyzed c-kit-
positive/tryptase-negative cells (Table 5).
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Fig. 2. Sample of ureter from patients with hydronephrosis stained for PDGFR alpha (red, Alexa Fluor 
594) and CD 34 (green, Alexa Fluor 488). Double immunopositive cells with elongated bodies located 
between muscle fi bers and close to blood vessels are identifi ed as telocytes (some of them are marked by 
arrow on the image). Total magnifi cation: 400×.
Table 5. Relative frequency of c-kit-positive/tryptase-negative, CD34-positive and PRGFRα-positive cells 
in ureteral wall of human unaff ected and aff ected by hydronephrosis patients. 0 = absence of telocytes, 
(+) = very few, + = few, + + = moderate density, + + + = multiple density.
Patients c-kit-positive / tryptase-negative cells
CD34-poisitve / PDGFRα-positive 
cells
Control group + + + +
Hydronephrosis (obstruction) (+) (+)
Hydronephrosis (vas) + +
Discussion
No one theory clearly explains the mechanisms of hydronephrosis development. We 
will consider several modern hypotheses in combination with focusing our attention 
on telocytes. Chuang et al. proposed that myocyte apoptosis leads to ureteral damage 
in the smooth muscle layer of obstructed ureters [30]. Th e congenital character of 
obstruction might also be connected with the co-existence of its apoptosis and local 
neuronal malformations in the ureteral wall [13]. Generally, cellular apoptosis is 
a result of the activation of the intrinsic and extrinsic pathways [31].
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Oxidative stress and extracellular stress signaling play a crucial role in these 
physiological processes. Among the main inductors of the extrinsic pathway, we 
distinguish tumor necrosis factor-α (TNF-α), a major infl ammatory cytokine in the 
human body, which also has a similar eff ect of telocytes population [32]. Decreasing 
of myocytes correlates with a fi brosis development and a grade of local infl ammation. 
Also, diseases, accompanied by fibrotic transformation, are characterized by an 
increasing number of inflammatory cells and declining of telocytes (or even 
disappearance): hepatic fi brosis, gallstone disease, systemic sclerosis, primary Sjögren’s 
syndrome, psoriasis, myocardial infarction uterine fi broid [33–41]. In ureteral tissue 
samples from hydronephrosis patients, we observed more mast cells in comparison 
with a control group. The opposite tendency has been revealed with TCs: in 
obstructive hydronephrosis were fewer cells, while in tissue samples with a  crossed 
vessel more than in obstruction, but less than in the control group. Telocytes make 
stromal synapses with mast cells and indirectly involved in the production of 
nitric oxide (a component of the oxidative stress). Meanwhile, in a renal ischemia‐
inflammatory injury model, they activated the nuclear factor kappa B signaling 
pathway and upregulated the mRNA levels of pro‐infl ammatory cytokines such as 
IL‐1 and tumor necrosis factor‐α [42, 43]. Infl ammation was common for both study 
groups (with obstruction and crossed vessels) and has not clarifi ed a diff erence in both 
kinds of hydronephrosis. Th at is why we delved into the study of TCs in divided study 
groups. We can hypothesize that the involvement of telocytes in the infl ammatory 
response could correlate with ureteral fibrosis and hydronephrosis development. 
Koleda et al. observed the link between age-related changes in the interstitial cell of 
Cajal-like cells density in congenital ureteropelvic junction. He concluded that the 
number of Interstitial cells of Cajal-like cells-dense fi elds decreasing with age may 
show the failure of compensation and regression of the compensatory changes [44]. 
We can extrapolate these data on our study and suspect that a low amount of TCs 
refl ects a low adaptative feature of the ureteral wall and as a result — high risk of 
hydronephrosis development.
Th e next interesting feature of TCs, especially in the urinary tract, is the existence 
of several layer-specifi c subpopulations of these cells. Th ey diff er from each other in 
some ultrastructural features and immunolabelling according to their location [28, 45]. 
Th e diff erence of immunopositivity of such markers as plated-derived growth factor 
receptor alpha (PDGFRα), α-smooth muscle actin (αSMA) and c-kit is typical for TCs 
in the urinary bladder. For instance, Vannucchi et al. published that in the submucosa 
of the human urinary bladder they are CD34/calret-positive, but PDGFRα/αSMA/c-
kit negative. Cells located immediately under the urothelium were PDGFRα/ calret-
positive and αSMA/CD34/c-Kit-negative, despite located deeper in the sub-urothelium 
— αSMA-positive. Dobra et al. described three diff erent subsets of ureteral TCs which 
are neither endothelial nor epithelial in nature: (a) type I: the CD34-/CD105+ TCs of 
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the superfi cial layer of lamina propria; (b) type II: the CD34+/CD105± myoid TCs of 
the deep layer of lamina propria and (c) type III: the CD34+/CD105+ perivascular 
TCs [45]. Although diff erent, all these subsets of TCs could belong to the stem/
progenitor niche of the ureter. Our aim has not included the diff erentiation of TCs in 
the ureteral wall, but we observed TCs located close to blood vessels and also under 
uroepithelium. No signifi cant diff erence in the location of TC in cases of obstructive 
hydronephrosis and resulted by crossed vessels has been observed.
Important to note is that telocytes have an significant role in pyeloureteric 
peristalsis [46]. Lang et al. described telocytes in UPJ and atypical smooth muscle 
cells as two populations of pacemaker cells [47]. Koleda et al. mentioned that telocytes 
express vanilloid receptor-like 1 protein (VRL-1/TRPV2) suggests the role they may 
have in the modulation of pyeloureteric peristalsis as sensors of physical and chemical 
stimuli [44]. His command also experimentally proved that the density of UPJ 
telocytes was diff erent among normal ureters and obstructed. Increased expression 
of c-kit-positive telocytes in congenital UPJO may indicate the development of 
a  compensatory mechanism for the failure of urine to be propelled from the renal 
pelvis through the ureter [44]. Li et al. showed that injection of renal TCs can 
attenuate renal dysfunction and ameliorate renal histological damage following renal 
ischemia-reperfusion injury [43].
Telocytes have gene expression profi les with up- and down-regulated genes 
on 1, 2, 3, 4, 17 and 18 chromosomes. Up-regulated genes functions common for 
these type of cells are related to cellular signaling, cell expansion and movement 
(migration, adhesion, migration, and division), embryogenesis, morphogenesis 
and tissue homeostasis (including immune homeostasis), tissue remodeling and 
repair, maintenance of oxidative microenvironment preventing tumorigenesis 
and anti-inflammatory responses. Until now, we do not know how TCs are 
involved in the pathogenesis of hydronephrosis, initiated by obstruction or vessel’s 
co-location [48– 54]. Due to their immunohistochemical profi le we know that they 
are involved in contraction of excitable tissue, positive for sex steroid hormones 
and probably may be involved in obstruction of the ureter by ovarian vessel, 
physiologically occurs during pregnancy. Our preliminary results showed that 
both ureteral tissue samples (from obstructive and crossed vessels) hydronephrosis 
have more mast cells and an increased amount of collagen, correlated with 
a decreasing in TCs density. More detailed observation of macro- and microscopic 
tissue organization showed a  slight diff erence in TCs between both study groups 
and collagen/muscle fibers ration as well. We intend to continue our research, 
which requires more specific analysis for stressing the role of telocytes in the 
pathomechanisms of hydronephrosis.
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